Stocks
Denali Therapeutics (DNLI) EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| EBITDA, bln rub | ? | -287.2 | -330.4 | -180.0 | -492.9 | -497.6 | -526.6 | |
| Changes by years, y/y, % | -558% | +15% | -46% | +174% | +1% | |||
Denali Therapeutics. EBITDA US GAAP, bln rub
Denali Therapeutics. EBITDA US GAAP, changes, %
Denali Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Denali Therapeutics (DNLI) EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -142.4 | -131.0 | -133.6 | -124.7 | -137.4 | -526.6 | |
| Changes by years, y/y, % | +9% | +14% | +10% | -2% | -4% | |||
| Changes by quarters, q/q, % | +12% | -8% | +2% | -7% | +10% | |||
